
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+15
Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bring cancer treatments and regenerative therapies to patients with unmet medical needs worldwide. We work in partnership with physicians and other healthcare providers to expand access to new therapies. Our clinical research program includes: CAR T, CAR NK, our proprietary Adapter CARTM and induced pluripotent stem cells (iPSC) technologies. For more information, please visit our website at www.miltenyibiomedicine.com
Clinical applications,clinical development,clinical trials,car-t cells,gene therapy,cell therapy,immunology,stem cell research,cancer research,car-t technology,immunotherapy,autologous t cells,research,innovation,innovative therapies,personalized cell and gene therapies,hematological cancers,optimizing patient outcomes,fresh cells approach,and biopharma
Miltenyi biomedicine operates in the Pharmaceutical manufacturing industry.
Miltenyi biomedicine's revenue is 11m - 100m
Miltenyi biomedicine has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.